Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia

被引:44
|
作者
Schubert, R
Reichenbach, J
Zielen, S
机构
[1] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[2] Univ Bonn, Dept Paediat, Bonn, Germany
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2002年 / 129卷 / 01期
关键词
ataxia telangiectasia; CD4(+) cells; CD45RA(+) (naive) lymphocytes; CD8(+) cells; T cell activation;
D O I
10.1046/j.1365-2249.2002.01830.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic sinopulmonary infections that are associated with immunodeficiency are one of the leading causes of death in the multi-systemic disease ataxia telangiectasia (AT). Immunological investigations of AT patients revealed a broad spectrum of defects in the humoral and the cellular immune system. Based on their important role in host defence the aim of our study was an extensive analysis of cell distribution and function of CD4(+) and CD8(+) T lymphocytes and NK cells. We found that naive (CD45RA(+) ) CD4(+) lymphocytes, as well as CD8(+) /CD45RA(+) lymphocytes, are decreased, whereas NK cells (CD3(-) /CD16(+) CD56(+) ) are significantly elevated in AT patients. In our culture system proliferation and cytokine production was normal in purified memory (CD45RO(+) ) lymphocytes after stimulation with phorbol-12,13-dibutyrate (PBu2 ) and after PHA activation, indicating that differences in proliferation and cytokine production are due solely to reduced numbers of CD45RA(+) lymphocytes. However, activation, and especially intracellular interferon production of AT lymphocytes, seem to follow different kinetics compared to controls. In contrast to polyclonal activation, stimulation via the T cell receptor results consistently in a reduced immune response. Taken together, our results suggest that deficiency of immunocompetent cells and an intrinsic immune activation defect are responsible for the immunodeficiency in AT.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 50 条
  • [31] Investigation of novel CD4+ and CD8+ cell subsets in the lungs of mice infected with Bordetella pertussis
    Dunne, P. J.
    Fennelly, N. K.
    Tully, C.
    Mills, K. H.
    IMMUNOLOGY, 2007, 120 : 9 - 9
  • [32] Similarities and differences in CD4+ and CD8+ effector and memory T cell generation
    Robert A Seder
    Rafi Ahmed
    Nature Immunology, 2003, 4 : 835 - 842
  • [33] A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets
    Watanabe, M
    Hara, Y
    Tanabe, K
    Toma, H
    Abe, R
    INTERNATIONAL IMMUNOLOGY, 2005, 17 (03) : 269 - 278
  • [34] CD4+ CD8+ T Cell Reference Values in the Mexico City Population
    Moreno-Galvan, Monica
    Palafox, Aracely
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (02) : 306 - 308
  • [35] REGULATION OF FIBROBLAST ACTIVITIES BY CD4+ AND CD8+ T-CELL CLONES
    NEEDLEMAN, BW
    YUROVSKY, V
    CHOI, J
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S312 - S312
  • [36] DNA methylation secures CD4+ and CD8+ T cell lineage borders
    Yongqiang Feng
    Alexander Y Rudensky
    Nature Immunology, 2015, 16 : 681 - 683
  • [37] Chronological changes of CD4+ and CD8+ T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
    Sonobe, Yoshifumi
    Jin, Shijie
    Wang, Jinyang
    Kawanokuchi, Jun
    Takeuchi, Hideyuki
    Mizuno, Tetsuya
    Suzumura, Akio
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 213 (04): : 329 - 339
  • [38] CD4+ and CD8+ T-Cell Skewness in Classic Kaposi Sarcoma
    Galleu, Antonio
    Fozza, Claudio
    Simula, Maria Pina
    Contini, Salvatore
    Virdis, Patrizia
    Corda, Giovanna
    Pardini, Simonetta
    Cottoni, Francesca
    Pruneddu, Sara
    Angeloni, Antonio
    Ceccarelli, Simona
    Longinotti, Maurizio
    NEOPLASIA, 2012, 14 (06): : 487 - 494
  • [39] T-CELL PROLYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL PHENOTYPE CD4+ CD8+
    KLUINNELEMANS, HC
    GMELIGMEYLING, FHJ
    KOOTTE, AMM
    DENOTTOLANDER, GJ
    TERMIJTELEN, A
    KLUIN, PM
    BEVERSTOCK, GC
    BRAND, A
    CANCER, 1987, 60 (04) : 794 - 803
  • [40] Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients
    Borros Arneth
    Inflammation, 2016, 39 : 2040 - 2044